169172 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Endothelial cells
HIGH-THROUGHPUT LONG-TERM CULTURED ENDOTHELIAL ORGANOID WITH ANGIOGENESIS
#2ANIMAL MODELS AND METHODS OF USE
#3SYSTEM FOR MEASURING METASTATIC POTENTIAL OF CANCER CELLS AND METHOD FOR MEASURING METASTATIC POTENTIAL OF CANCER CELLS BY USING SAME
#4METHOD FOR IMPROVING TRANSCYTOSIS PROPERTIES OF HUMAN BLOOD-BRAIN BARRIER MODEL
#5USE OF PI3KC2B INHIBITORS FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY
#6QUANTIFICATION OF CIRCULATING REGENERATIVE AND ENDOTHELIAL PROGENITOR CELLS AS PREDICTORS OF HEALTH STATUS
#7MODULATING VENULENESS OF ENDOTHELIAL CELLS
#8PROTEINS COMPRISING BLOOD BRAIN BARRIER (BBB)-BINDING DOMAINS WITHIN CONSTANT DOMAINS
#9TARGETING VON WILLEBRAND FACTOR TO MODEL DISEASE IN HUMAN PLURIPOTENT STEM CELLS
#10USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION
#11METHOD OF PRODUCING BRAIN MICROVASCULAR ENDOTHELIAL-LIKE CELLS AND USE THEREOF
#12ASSAY METHODS FOR SCREENING INHIBITORS OF SICKLE CELL DISEASE, ß-THALASSEMIA, OR SICKLE CELL ß-THALASSEMIA, OR A PHENOTYPE THEREOF
#13PHYSIOLOGY AND PATHOPHYSIOLOGY OF HUMAN GUT: INTESTINE-ON-CHIP
#14ORGANS-ON-CHIPS AS A PLATFORM FOR EPIGENETICS DISCOVERY
#15USE OF ENHANCED TBX1 EXPRESSION IN REPAIRING HEART TISSUE INJURY
#16RHEOLOGICALLY BIOMIMETIC FLUID SURROGATE
#17MICROFLUIDIC PROXIMIAL TUBULE KIDNEY-ON-CHIP
#18IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECS)
#19GENERATING ARTERIAL ENDOTHELIAL CELL POPULATIONS
#20USE OF PI3KC2B INHIBITORS FOR THE PRESERVATION OF VASCULAR ENDOTHELIAL CELL BARRIER INTEGRITY
#21ENHANCING BLOOD-BRAIN BARRIER DRUG TRANSPORT BY TARGETING ENDOGENOUS REGULATORS
#22COMPOSITIONS AND METHODS FOR REGULATING LEUKOCYTE ADHESION
#23CELLULAR-BASED METHOD FOR DETERMINING THE POTENCY OF DEFIBROTIDE
#24Physiology and pathophysiology of human gut: intestine-on-chip
#25COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) AND IMMUNE CHECKPOINT BLOCKERS
#26IN VITRO METHOD FOR DETERMINING THE LIKELIHOOD OF OCCURRENCE OF AN ACUTE MICROVASCULAR REJECTION (AMVR) AGAINST A RENAL ALLOGRAFT IN AN INDIVIDUAL
#27ORGAN MODELS
#28METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE
#29Additive Manufacturing of Functional Myocardial Tissue
#30METHOD FOR CHARACTERISING A TISSUE-ENGINEERED CONSTRUCT
#31IN VITRO HUMAN BLOOD BRAIN BARRIER
#32Microfluidic proximal tubule kidney-on-chip
#33UREMIC VASCULOPATHY MODEL USING ENDOTHELIAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS AND UREMIC COMPLEX, AND USE THEREOF
#34MICROPHYSIOLOGICAL CHOROID MODEL
#35COLUMN-BASED DEVICE AND METHOD FOR RETRIEVAL OF RARE CELLS BASED ON SIZE, AND USES THEREOF
#36Methods of making hydraulic fracturing fluids and use thereof
#37HUMAN BLOOD-BRAIN BARRIER MODEL DERIVED FROM STEM CELLS
#38METHODS FOR ASSESSING TRANSENDOTHELIAL BARRIER INTEGRITY
#39Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity
#40Neamine Compositions and Methods of Use Thereof
#41MODEL FOR IN-VITRO SIMULATION OF THE BEHAVIOUR OF DYSFUNCTIONAL VESSELS
#42Column-based device for retrieval of rare cells based on size, and uses thereof
#43Target for diabetes treatment and prevention
#44Platform for assessment of the transcytosis of extracellular vesicles across endothelial barriers and uses thereof
#45Organs-on-chips as a platform for epigenetics discovery
#46NOVEL SCREENING METHOD FOR TGF-BETA INHIBITOR
#47Rheologically biomimetic fluid surrogate
#48Methods, Systems, And Compositions For Determining Blood Clot Formation, And Uses Thereof
#49Identification and isolation of human corneal endothelial cells (HCECs)
#50Microfluidic kidney-on-chip
#51CIRCULATING TUMOR CELL ASSAY
#52Methods for screening personal care products
#53BLOOD VESSEL MODEL
#54Living tissue model device, vascular wall model, vascular wall model device and method of evaluating test substance
#55CELLULAR-BASED METHOD FOR DETERMINING THE BIOLOGICAL ACTIVITY OF DEFIBROTIDE
#56Additive manufacturing of functional myocardial tissue
#57SYNTHETIC BLOOD VESSELS AND USES THEREOF
#58METHODS FOR IDENTIFYING METAP-2 MODULATORS
#59Vascularized In Vitro Perfusion Devices, Methods of Fabricating, and Applications Thereof
#60Juvenile atopic dermatitis models
#61Three-dimensional (3D) hydrogel patterning in microfluidic vascular models
#62IN-VITRO METHOD FOR IDENTIFYING AND ANALYSING ION CHANNELS AND/OR WATER CHANNELS AND/OR RECEPTORS OF SIGNAL TRANSDUCTION USING A THREE-DIMENSIONAL CELL CULTURE MODEL OF THE SWEAT GLAND
#63Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
#64In vitro model for blood-brain barrier and method for producing in vitro model for blood-brain barrier
#65Induction of corneal endothelial cells
#66Anti-cancer drug assessment method
#67BLOOD VESSEL MODEL
#68LIVING TISSUE MODEL DEVICE, VASCULAR WALL MODEL, VASCULAR WALL MODEL DEVICE AND METHOD OF EVALUATING TEST SUBSTANCE
#69CELL CULTURE MODEL OF VASCULAR CALCIFICATION
#70Synthetic blood vessels and uses thereof
#71FLUIDIC DEVICES INCORPORATING FUNCTIONAL MUSCLE TISSUE AND METHODS OF USE
#72Compositions and methods for regulating leukocyte adhesion
#73MULTILAYER SHEET OF CELLS
#74Method for measuring coagulation of blood samples using viscoelastic tests (VET)
#75RESPIRATION DEVICE FOR ANALYSIS OF A RESPONSE TO SHEAR STRESS AND FOREIGN AGENTS ON CELLS
#76CIRCULATING TUMOR CELL ASSAY
#77Column-based device and method for retrieval of rare cells based on size, and uses thereof
#78Cellular-based method for determining the biological activity of defibrotide
#79Bio-assessment device and method of making the device
#80Methods for measuring and reporting vascularity in a tissue sample
#81Devices for fluid management
#82Multi-organ media compositions and methods of their use
#83In vitro blood-brain barrier model
#84SCALABLE ORGANOTYPIC MODELS OF TUMOR DORMANCY
#85Mechanical stress response analysis of cells and tissues
#86Three-dimensional silk fibroin scaffold culture retaining functional salivary cells and promoting salivary tissue-specific ECM synthesis
#87Method for generating endothelial colony forming cell-like cells
#88METHOD FOR TESTING FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND METHOD FOR SCREENING AGENT FOR TREATMENT OF THE DISEASE
#89Vascularized in vitro perfusion devices, methods of fabricating, and applications thereof
#90Target for diabetes treatment and prevention
#91Microvessel endothelial cell surface markers and uses thereof
#92Ported parallel plate flow chamber and methods for use thereof
#93Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
#94Generating arterial endothelial cell populations
#95Covalently-immobilized hydrogel arrays in multi-well plates
#96Methods for diagnosing and treating asthma
#97Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures
#98Identification and isolation of human corneal endothelial cells (HCECS)
#99A HUMAN BLOOD-BRAIN BARRIER MODEL DERIVED FROM STEM CELLS
#100Method of treatment for pulpitis and/or enhancement for dentinogenesis
#101Skin model
#102Skin activation by acceleration of PDGF-BB activity
#103Induced pluripotent stem cell model for Fabry disease and use thereof
#104Method for measuring coagulation of blood samples using viscoelastic tests (VET)
#105Methods for Efficient Immortalization Of Normal Human Cells
#106Methods and compounds for increasing threonyl-tRNA synthetase activity
#107Monitoring and Modulating HGF/HGFR Activity
#108Endothelial cell production by programming
#109High throughput sensitization detection devices and methods
#110ENDOTHELIAL CELL CULTURE
#111Ported parallel plate flow chamber and methods for use thereof
#112Method for producing intestinal cells
#113Method Of Treatment Of Vascular Complications
#114Microfluidic biological barrier model and associated method
#115Device for high throughput investigations of multi-cellular interactions
#116Small molecules for endothelial cell activation
#117Function homology screening
#118Daikenchuto bioassay method and quality management method using same
#119Three-dimensional, prevascularized, engineered tissue constructs, methods of making and methods of using the tissue constructs
#120METHODS OF MODULATING ANGIOGENESIS VIA TRPV4
#121Monitoring and modulating HGF/HGFR activity
#122Composition comprising an angiopoietin-4 fragment
#123Human and murine stem-cell lines: models of endothelial cell precursors
#124Methods of Modulating Thrombocytopenia and Modified Transgenic Pigs
#125Organ-specific feline endothelial cells and uses thereof
#126In vitro tumor angiogenesis model
#127METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#128Method for Treating Arteriosclerosis
#129Compositions and methods for inducing angiogenesis
#130METHODS AND USES FOR TREATING HEPATIC ISCHEMIA AND REPERFUSION INJURY
#131METHOD FOR INFORMING A PURCHASER OF A TOPICAL SKIN CARE PREPARATION OF AN OXIDATIVE STRESS PROTECTIVE CAPACITY
#132Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
#133METHOD OF TREATMENT OF VASCULAR COMPLICATIONS
#134CELL EVALUATION SYSTEM USING CELL SHEET AND METHOD FOR USING THE SYSTEM
#135METHOD FOR THE SELECTION OF ENDOTHELIAL CELLS DEATH INDUCERS VIA NETRIN-1 AND ITS APPLICATIONS
#136Endothelial cell production by programming
#137Method to detect endothelial cell massive calcium accumulation death
#138Detection of Activation of Endothelial Cells as Surrogate Marker for Angiogenesis
#139Neamine Compositions and Methods of Use Thereof
#140Methods for diagnosing and treating asthma
#141METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#142METHODS FOR USING AND IDENTIFYING MODULATORS OF DELTA-LIKE 4
#143IN VITRO SCREENING ASSAYS
#144METHOD FOR SCREENING FOR ANTIANGIOGENIC AGENT, AND METHOD FOR SCREENING FOR ANTIANGIOGENIC SIGNAL GENE
#145Methods of modulating angiogenesis via TRPV4
#146FUNCTIONAL LAYERS OF BIOMOLECULES AND LIVING CELLS, AND A NOVEL SYSTEM TO PRODUCE SUCH
#147BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#148MEDICAMENT, DENTAL MATERIAL, AND METHOD OF SCREENING
#149Compositions and methods for inducing angiogenesis
#150Detection of Changes in Cell Populations and Mixed Cell Populations
#151Methods of identifying agents that inhibit angiogenesis
#152Methods of evaluating a test agent in a diseased cell model
#153In-Vitro Model of Blood-Brain Barrier, In-Vitro Model of Diseased Blood-Brain Barrier, and Drug Screening Method, Analysis Method for Functions of Diseased Blood-Brain Barrier, and Analysis Method for Pathogenesis Using the Same
#154JNK3 as a target for the treatment of angiogenesis-related diseases
#155METHODS FOR TREATMENT AND/OR PREVENTION OF A DISEASE ASSOCIATED WITH VASCULAR LEAK
#156Method of Screening for RAGE-Amyloid-Beta Peptide Interaction Inhibiting Materials
#157Method or system using biomarkers for the monitoring of a treatment
#158MONITORING AND MODULATING HGF/HGFR ACTIVITY
#159Method of screening endothelial cells for angiogenic capability
#160Disease model incorporation into an artificial immune system (AIS)
#161Compositions and Methods for Treating Peripheral Vascular Diseases
#162In vitro tumor angiogenesis model
#163METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OR STABILIZATION OF FIBROSIS
#164Methods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
#165ASSESSING MAMMALS FOR VASCULAR DISEASES AND VALVULAR DISEASES
#166METHODS OF SCREENING FOR COMPOUNDS FOR USE AS MODULATORS OF LEFT-RIGHT ASYMMETRY IN SCOLIOTIC SUBJECTS AND FOR MONITORING EFFICACY OF AN ORTHOPAEDIC DEVICE
#167Method of Using CD100 (or Sema4D) to Mediate Platelet Activation and Inflammatory Responses
#168METHODS AND COMPOSITIONS FOR VASCULOGENIC POTENTIAL DETERMINATION
#169Circulating tumor cell assay
#170Use of Crystallin For The Modulation of Angiogenesis
#171Methods to identify therapeutic agents
#172Methods for identifying agents and their use for the prevention of restenosis
#173Methods to identify therapeutic agents
#174Measuring free choline to determine suitability of erythrocytes for transfusion
#175CELL CULTURE SYSTEM, PROCESS FOR THE PRODUCTION THEREOF, AND THE USE THEREOF IN PRECLINICAL INVESTIGATION
#176Targeted Delivery of Compounds Using Multimerization Technology
#177NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS
#178Angiogenic peptides and uses thereof
#179Method for treating vascular disorders
#180Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
#181Cellular upregulation of VEGF receptor expression using nanofibrillar articles
#182METHODS OF SCREENING FOR COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY
#183Systems and methods for screening pharmaceutical chemicals
#184BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#185Methods for using and identifying modulators of Delta-like 4
#186Disease model incorporation into an artificial immune system (AIS)
#187Method to improve barrier function of cell-cell junctions
#188Inhibition of Bradykinin Release
#189Cytotrophoblast Stem Cell
#190Methods and Compositions for Treating Epithelial Cancers
#191FUNCTION HOMOLOGY SCREENING
#192FUNCTION HOMOLOGY SCREENING
#193BIOMAP ANALYSIS
#194Methods And Compositions For Screening Involving Endothelial Cells Under Shearing Conditions
#195TREATMENT METHODOLOGIES FOR PREVENTING REFLUX INDUCED ADENOCARCINOMA OF THE ESOPHAGUS
#196Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the Dame
#197BV8 nucleic acids and polypeptides with mitogenic activity
#198Methods for Modifying Cell Motility Using Factor VIIa Antagonist
#199Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes
#200SVCT2 transporters expressed in blood brain barrier cells
#201Methods for using and identifying modulators of Delta-like 4
#202Method for producing vascular wall lesion using platelets
#203Microaggregates including endothelial cells
#204METHODOLOGIES FOR THE DIAGNOSIS AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
#205Methods for Identifying Target Genes, Gene Expression Profiles, and Biochemical/Signal Transduction Pathways Associated with Specific Patterns of Hemodynamic Shear Stress and Atherogenesis and Uses Thereof
#206Screening of compounds for OCTN2 transporter activity
#207Screening of compounds for BGT1 transporter activity
#208Marker for fenestrae
#209Methods of treating cancer, arthritis and/or diabetes with angiopoietins
#210Methods and compositions for inhibiting angiogenesis
#211In vitro tumor angiogenesis model
#212Secreted and transmembrane polypeptides and nucleic acids encoding the same
#213OPIATE, CANNABINOID, AND ESTROGEN RECEPTORS
#214Methods for characterizing signaling pathways and compounds that interact therewith
#215Screening of compounds for GAT2 transporter activity
#216Angiogenic peptides and uses thereof
#217METHODS TO IDENTIFY THERAPEUTIC AGENTS
#218Screening of compounds for CAT1 transporter activity
#219Screening of compounds for OCT3 transporter activity
#220Human secreted proteins
#221Uniqueness products acquisition system
#222Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
#223Disease model incorporation into an artificial immune system (AIS)
#224Purposeful movement of human migratory cells away from an agent source
#225Monitoring and modulating HGF/HGFR activity
#226Interleukin-2 muteins
#227In vitro test system for predicting patient tolerability of therapeutic agents
#228Bv8 nucleic acids and polypeptides with mitogenic activity
#229Detection of activation of endothelial cells as surrogate marker for angiogenesis
#230Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
#231Method for identifying active anti-apoptosis compounds
#232Method for characterizing the oxidative stress protective capacity of an antioxidative substance
#233Treatment of neovascularization disorders with squalamine
#234Combinatorial interleukin-2 muteins
#235Cellular microarrays for screening differentiation factors
#236Inhibition of bradykinin release
#237Method of using CD100 (or Sema4D) to mediate platelet activation and inflammatory responses
#238Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene
#239Method for diagnosing a pre-neoplastic or neoplastic lesion in transitional epithelial cells
#240Bioprosthetic heart valves
#241Isolation of endothelial progenitor cell subsets and methods for their use
#242Angiogenic compounds and uses thereof
#243Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
#244Modulators of angiogenesis and tumorigenesis
#245Methods for modifying cell motility using factor VIIa antagonist
#246High throughput screening assay systems in microscale fluidic devices
#247Methods for inhibiting vascular permeability
#248TAUT1 transporters expressed in blood brain barrier cells
#249Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
#250Real-time impedance assay to follow the invasive activities of metastatic cells in culture
#251Modulators of angiogenesis and tumorigenesis
#252Methods for inhibiting vascular permeability
#253Cell line comprising vector encoding truncated FLK-1 receptor
#254Method of screening endothelial cells for angiogenic capability
#255In vitro assay for evaluation of angiogenic effects
#256New drug
#257Cell-free assay for insulin signaling
#258Extracellular matrix signaling molecules
#259Remedies for heart diseases
#260Methods, systems, and compositions for determining blood clot formation, and uses thereof